The Pericapsular Nerve Block in Total Hip Arthroplasty

Part of paid clinical trials in Baltimore, Maryland.

Sponsor
LifeBridge Health
Study ID
NCT04729686
Phase
PHASE4
Status
Recruiting

Conditions

Eligibility Criteria

Sex
ALL
Age
18 Years - 80 Years
Healthy Volunteers
Not accepted

Interventions

  • Pericapsular Nerve Block — DRUG
    Per Standard Institutional Practice
  • Fascia Iliaca Nerve Block — DRUG
    Per Standard Institutional Practice

Study Details

In order to continue progressing towards outpatient total hip arthroplasty (THA), methods to adequately manage postoperative pain is of paramount importance. The purpose of this study is to quantify the effectiveness of the pericapsular nerve block in total hip arthroplasty in comparison to the fascia iliaca nerve block.

Key Dates

Start date
Dec 9, 2020
Status verified
Nov 2024
Primary completion
Dec 1, 2025
Completion
Dec 1, 2025

Study Design

Enrollment
78 participants (estimated)
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT

Arms

  • Active Comparator: Pericapsular Nerve Block Group
    Pericapsular Nerve Block targets the anterior hip capsule by blocking the articular branches of the femoral nerve and accessory obturator nerve.
  • Active Comparator: Fascia Iliaca Nerve Block Group
    Fascia Iliaca Nerve Block targets the space between the iliacus muscle and the fascia that overlies it (fascia iliaca), within which the femoral nerve and lateral femoral cutaneous nerve (LFCN) course.

Primary Outcome Measure

Change in Visual Analog Pain Scale (VAS) Score [ Time Frame: Every 4 hours from end of surgery to 48 hours post surgery or discharge ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
Sinai Hospital of BaltimoreBaltimoreMaryland21215
Martin Gesheff
Ronald Delanois, MD (PRINCIPAL_INVESTIGATOR)
James Nace, DO (SUB_INVESTIGATOR)
Ethan Remily, DO (SUB_INVESTIGATOR)

Find similar trials in Baltimore, MD

Related Studies